Skip to main content
A scary good deal on trusted journalism
Get full digital access to globeandmail.com
$0.99
per week for 24 weeks SAVE OVER $140
OFFER ENDS OCTOBER 31
A scary good deal on trusted journalism
$0.99
per week
for 24 weeks
SAVE OVER $140
OFFER ENDS OCTOBER 31
// //

Steris Corp NYSE: STE-N

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 224.74
Day High 229.42
Open:224.74
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company's operating segments consists of Healthcare, Life Sciences and STERIS Isomedix Services. Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries and service solutions to pharmaceutical companies and private and public research facilities. Isomedix segment sells an array of contract processing services as well as laboratory testing services. Steris Plc, formerly known as STERIS Corporation, is headquartered in Leicester, United Kingdom.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

STERIS Announces Financial Results for Fiscal 2022 First Quarter
- GlobeNewswire - Mon Aug 9, 4:09PM CDT
GlobeNewswire - CMTX
Mon Aug 9, 4:09PM CDT
STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2022 first quarter ended June 30, 2021. Revenue as reported for the quarter increased 45% to $968.4 million compared with $668.9 million in the first quarter of fiscal 2021. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 21% for the first quarter of fiscal 2022 as compared to the first quarter of fiscal 2021, which was negatively impacted by the pandemic.
STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021
- GlobeNewswire - Tue Jul 27, 8:07AM CDT
GlobeNewswire - CMTX
Tue Jul 27, 8:07AM CDT
STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2022 first quarter financial results at 10:00 a.m. ET on Tuesday, August 10, 2021. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
Pembrook Appoints Advisors for Affordable Housing Lending Business, Broadening Efforts to Address Economic and Racial Inequality
- PR Newswire - PRF - Tue Jul 27, 7:53AM CDT
PR Newswire - PRF - CMTX
Tue Jul 27, 7:53AM CDT
/PRNewswire/ --Pembrook Capital Management LLC ("Pembrook"), a leading national lender focused on affordable rental housing investments, has appointed two Senior Advisors to expand the firm's efforts to address racial and economic inequality through its affordable housing lending business.  , CEO of Pembrook, made the announcement.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 202.03 +12.37% increase
on 10/01/21
Period Open:215.09
Price movement based on the high, low and last over the given period.
229.42 -1.04% decrease
on 10/19/21
+11.94 (+5.55%) increase
since 09/17/21
3-Month 202.03 +12.37% increase
on 10/01/21
Period Open:204.30
Price movement based on the high, low and last over the given period.
229.42 -1.04% decrease
on 10/19/21
+22.73 (+11.13%) increase
since 07/19/21
52-Week 170.36 +33.26% increase
on 03/04/21
Period Open:186.43
Price movement based on the high, low and last over the given period.
229.42 -1.04% decrease
on 10/19/21
+40.60 (+21.78%) increase
since 10/19/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies